Dr. David Rabin, MD, PhD is a guy who designed a fascinating wearable that he showed me a few weeks ago when he came to my house in Spokane, WA. A board-certified psychiatrist, translational neuroscientist, and inventor specializing in the treatment of post-traumatic stress disorder (PTSD), depression, anxiety, and substance use disorders, Dr. Rabin has spent the last 14 years researching treatments to combat the negative effects of chronic stress on physical and mental health. He received his MD in medicine and his PhD in neuroscience from Albany Medical College and trained in psychiatry at Western Psychiatric Institute & Clinic at the University of Pittsburgh Medical Center. Dr. Rabin helped to organize the in collaboration with colleagues at Yale, the University of Southern California, Mt. Sinai, Modern Spirit, and MAPS (Multidisciplinary Association of Psychedelic Studies) to determine the mechanisms of the dramatic therapeutic benefits observed following psychedelic-assisted psychotherapy in treatment-resistant mental illness. The study has begun and is collecting DNA samples from patients with treatment-resistant PTSD who are participating in the MAPS-sponsored Phase 3 FDA trial of MDMA-assisted psychotherapy to evaluate the gene expression changes that result from the therapy. He is also the founder and executive director of the Board of Medicine, a nonprofit organization of physicians and scientists spearheading the development of the world’s first evidence-based peer-reviewed clinical guidelines for the safe use of complementary and alternative medicines including medical cannabis. Dr. Rabin works with patients with treatment-resistant conditions like post-traumatic stress disorder (PTSD), depression, and substance use disorders. In his work, he found that when patients were in a calm, safe environment their physiological markers of stress improved, their mood got better, and they were better able to focus and manage their symptoms. He also found that mindfulness techniques and deep breathing worked quite well to reduce stress in patients, but that his patients had a difficult time practicing these techniques on their own in their day-to-day lives. In 2014, Dr. Rabin began his research on what would become the device I'm referring to, "Apollo" in a neuroscience lab at the University of Pittsburgh. After exploring academic research on mindfulness, biofeedback, deep breathing, and a host of sensory techniques including music therapy, Dr. Rabin found that touch is an often overlooked, but an incredibly vital pathway for quickly establishing relaxation in the mind and in the body. He quickly got to work developing , a breakthrough wearable technology that uses the neuroscience of touch and vibration to combat the negative effects of stress during his research at the University of Pittsburgh. sends gentle waves of vibration to your body that are clinically shown to bring your heart, lungs, and mind into balance, resulting in improved heart rate variability (HRV). By signaling safety to the body through your sense of touch, Apollo offers you control over your stress, so you can tackle whatever comes next. After clinical trials of the Apollo technology demonstrating its reliable effects on mood, sleep, and focus, Dr. Rabin co-founded  to make the discovery available to the public. Chronic stress tells your body that you’re under threat. These consistent disturbances put your body into fight-or-flight, making it difficult to stay calm, focus your attention, and get good sleep. ’s vibrations work by signaling safety to the brain, thereby soothing the stress response and rapidly restoring balance to the body. has created the first wearable system that upgrades your body instead of just tracking it. Clinical studies show that Apollo increases physical endurance, , , and helps users reach relaxation before bed rapidly by . Apollo’s effects occur within 5 minutes of use and have no known side effects. Apollo’s AI mobile app del